Skip to main content
. 2020 Aug 20;15(8):e0237464. doi: 10.1371/journal.pone.0237464

Table 2. Data-sharing statement details on trials registrations.

Non-commercial funded RCTs N = 100 Non-commercial funded RCTs N = 100
Data sharing plan in the registration? 77 [67% - 85%] 81 [72% - 88%]
Intention to share IPD
Yes 12 [7% - 20%] 59 [49%– 69%]
Undecided 12 [7%– 20%] 9 [4%– 17%]
No 54 [44%– 64%] 16 [10%– 25%]
Nothing specified 22 [15%– 32%] 16 [10%– 25%]
Information about supporting material availability? 12 [7%– 20%] 37 [28%– 47%]
Information about protocol availability? 11 [6%– 19%] 33 [25%– 44%]
Information about SAP availability? 9 [4%– 17%] 32 [23%– 42%]
Information about CSR availability? 6 [2%– 13%] 33 [24%– 43%]
Mention of timeframe of data availability? 11 [6%– 19%] 19 [12%– 28%]
Data will be freely accessible? 6 [2%– 13%] 26 [18%– 36%]
Mention of restriction of data access? 1 [0.5%– 6%] 12 [7%– 20%]
Mention of a specific aim for data reuse? 3 [0.7%– 9%] 6 [2%– 13%]
Mention of data access methods? 6 [2%– 13%] 47 [37%– 57%]

Data are presented as percentages and their corresponding 95% confidence intervals.